Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions
SEC Form 4 Filing
Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. stock and restricted stock units on February 15, 2025.
Summary
- On February 15, 2025, Tariq Musa, a director of Guardant Health, Inc., reported transactions involving the company's stock and restricted stock units.
- Musa acquired 250 shares of common stock at $0.
- Musa also disposed of 250 restricted stock units.
- Following these transactions, Musa directly owns 3,194 shares of common stock and 6,246 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing, reflecting standard insider trading activity. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how they interpret insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of restricted stock unit award grant. |
| 03/15/2023 | One-year anniversary of the restricted stock unit award grant, when 25% of the shares vested. |
| 02/15/2025 | Date of the reported stock and restricted stock unit transactions. |
| 02/18/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.